A reassessment of fasting plasma glucose concentrations in population screening for diabetes mellitus in a community of northern European ancestry: the Wadena City Health Study
- PMID: 7888688
- DOI: 10.1007/BF00571949
A reassessment of fasting plasma glucose concentrations in population screening for diabetes mellitus in a community of northern European ancestry: the Wadena City Health Study
Abstract
In current clinical and research practice, the determination of diabetic status depends largely on plasma glucose levels 2 h after the ingestion of a standard 75-g glucose load, the oral glucose tolerance test (OGTT). The OGTT, however, remains inconvenient, not highly reproducible, and costly, especially for large-scale studies and population screening tests. Fasting plasma glucose (FPG) determinations are convenient, reliable, and valid measures of glucose intolerance, but the currently prescribed cut-off point of 140 mg/dl (7.8 mM) lacks sensitivity. We evaluated the reliability and validity of fasting plasma glucose (FPG) values compared with other measures of hyperglycemia for a diagnosis of diabetes in a population-based study of carbohydrate metabolism in Wadena, Minnesota, a community of predominantly northern European ancestry. As a part of this effort, a random sample of Wadena adults, stratified by age and gender, plus all known, previously diagnosed diabetics participated in 2 days of baseline testing and were followed prospectively and retested 5 years later. Cross-sectional analyses of baseline data are presented in this article. Diabetic status was ascertained by administering a standard OGTT according to National Diabetes Data Group (NDDG) specifications. Sensitivity and specificity levels obtained when using a FPG cut-off point of 6.4 mM were 95.2% and 97.4%, respectively. In study subjects with no known diagnosis of diabetes, the FPG cut-off point of 6.4 mM performed reasonably well with a sensitivity and specificity of 67.7% and 97.4%, respectively. (ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2. Epub 2009 Sep 17. Acta Diabetol. 2010. PMID: 19760291
-
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.Diabetes Res Clin Pract. 2002 Jan;55(1):65-85. doi: 10.1016/s0168-8227(01)00365-5. Diabetes Res Clin Pract. 2002. PMID: 11755481
-
Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.Diabetes Care. 1998 Aug;21(8):1221-5. doi: 10.2337/diacare.21.8.1221. Diabetes Care. 1998. PMID: 9702423
-
Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.Acta Diabetol. 2003 Dec;40(4):181-6. doi: 10.1007/s00592-003-0109-8. Acta Diabetol. 2003. PMID: 14740278
-
[Diagnostic criteria for diabetes mellitus].Rinsho Byori. 1999 Oct;47(10):901-8. Rinsho Byori. 1999. PMID: 10590663 Review. Japanese.
Cited by
-
New ADA criteria in the Korean population: fasting blood glucose is not enough for diagnosis of mild diabetes especially in the elderly.Korean J Intern Med. 2000 Dec;15(3):211-7. doi: 10.3904/kjim.2000.15.3.211. Korean J Intern Med. 2000. PMID: 11242809 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials